Thomas Beetham
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas Beetham
Thomas Beetham was last confirmed as Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH) in a filing dated May 2, 2022. The proxy statement of Dianthus Therapeutics, Inc. /DE/ reports total compensation of $1,571,434 for Thomas Beetham in fiscal 2023, including a base salary of $300,294. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Proxy statement
Start not stated–2024-04-11
Last confirmed by a filing; no departure on record
-
Start not stated–2022-05-02
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Former Chief Legal Officer | $300,294 | $1,571,434 |
| 2021 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Chief Legal Officer | $230,681 | $1,894,380 |
Recent activity
No call appearances or filed executive changes recorded yet.